{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:56:47Z","timestamp":1786982207723,"version":"build-2736575974"},"reference-count":92,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T00:00:00Z","timestamp":1771977600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T00:00:00Z","timestamp":1771977600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"deputy of Research in the Hormozgan University of Medical Sciences, Bandar Abbas, Iran.","award":["4000409"],"award-info":[{"award-number":["4000409"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"DOI":"10.1007\/s12032-025-03102-8","type":"journal-article","created":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T03:14:14Z","timestamp":1771989254000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["FN1 as a key gene in modulating the integrin cell surface pathway in breast cancer"],"prefix":"10.1007","volume":"43","author":[{"given":"Mahboubeh","family":"Sadeghi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abbas","family":"Ghaderi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pegah","family":"Mousavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soudabeh","family":"Sabetian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amin","family":"Ramezani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Reza","family":"Haghshenas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,25]]},"reference":[{"issue":"4","key":"3102_CR1","first-page":"365","volume":"43","author":"VM Zangouri","year":"2018","unstructured":"Zangouri VM, Akrami MM, Tahmasebi SM, Talei AM, Ghaeini Hesarooeih AM. Medullary breast carcinoma and invasive ductal carcinoma: a review study. Iran J Med Sci. 2018;43(4):365\u201371.","journal-title":"Iran J Med Sci"},{"issue":"1","key":"3102_CR2","first-page":"24","volume":"5","author":"I Harirchi","year":"2004","unstructured":"Harirchi I, Karbakhsh M, Kashefi A, Momtahen AJ. Breast cancer in Iran: results of a multi-center study. Asian Pac J Cancer Prevent: APJCP. 2004;5(1):24\u20137.","journal-title":"Asian Pac J Cancer Prevent: APJCP"},{"issue":"1","key":"3102_CR3","first-page":"1","volume":"15","author":"DLP Brooks","year":"2016","unstructured":"Brooks DLP, Schwab LP, Krutilina R, Parke DN, Sethuraman A, Hoogewijs D, et al. ITGA6 is directly regulated by hypoxia-inducible factors and enriches for cancer stem cell activity and invasion in metastatic breast cancer models. Mol Cancer. 2016;15(1):1\u201319.","journal-title":"Mol Cancer"},{"issue":"2","key":"3102_CR4","volume":"11","author":"J-Y Ho","year":"2016","unstructured":"Ho J-Y, Chang F-W, Huang FS, Liu J-M, Liu Y-P, Chen S-P, et al. Estrogen enhances the cell viability and motility of breast cancer cells through the ER\u03b1-\u0394Np63-integrin \u03b24 signaling pathway. PLoS One. 2016;11(2):e0148301.","journal-title":"PLoS One"},{"issue":"4","key":"3102_CR5","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1159\/000358670","volume":"33","author":"H Zhang","year":"2014","unstructured":"Zhang H, Guo M, Chen J-H, Wang Z, Du X-F, Liu P-X, et al. Osteopontin knockdown inhibits \u03b1v, \u03b23 integrin-induced cell migration and invasion and promotes apoptosis of breast cancer cells by inducing autophagy and inactivating the PI3K\/Akt\/mTOR pathway. Cell Physiol Biochem. 2014;33(4):991\u20131002.","journal-title":"Cell Physiol Biochem"},{"issue":"10","key":"3102_CR6","volume":"14","author":"Y Wu","year":"2022","unstructured":"Wu Y, Liu X, Zhu Y, Qiao Y, Gao Y, Chen J, et al. Type IV collagen \u03b1 5 chain promotes luminal breast cancer progression through c-Myc-driven glycolysis. J Mol Cell Biol. 2022;14(10):mjac068.","journal-title":"J Mol Cell Biol"},{"key":"3102_CR7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13058-015-0579-y","volume":"17","author":"J Yuan","year":"2015","unstructured":"Yuan J, Liu M, Yang L, Tu G, Zhu Q, Chen M, et al. Acquisition of epithelial-mesenchymal transition phenotype in the tamoxifen-resistant breast cancer cell: a new role for G protein-coupled estrogen receptor in mediating tamoxifen resistance through cancer-associated fibroblast-derived fibronectin and \u03b21-integrin signaling pathway in tumor cells. Breast Cancer Res. 2015;17:1\u201318.","journal-title":"Breast Cancer Res"},{"issue":"4","key":"3102_CR8","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1111\/imm.13196","volume":"160","author":"Y Shu","year":"2020","unstructured":"Shu Y, Qin M, Song Y, Tang Q, Huang Y, Shen P, et al. M2 polarization of tumor-associated macrophages is dependent on integrin \u03b23 via peroxisome proliferator-activated receptor-\u03b3 up-regulation in breast cancer. Immunology. 2020;160(4):345\u201356.","journal-title":"Immunology"},{"issue":"1","key":"3102_CR9","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3390\/cancers5010027","volume":"5","author":"F Schaffner","year":"2013","unstructured":"Schaffner F, Ray AM, Dontenwill M. Integrin \u03b15\u03b21, the fibronectin receptor, as a pertinent therapeutic target in solid tumors. Cancers (Basel). 2013;5(1):27\u201347.","journal-title":"Cancers (Basel)"},{"issue":"7","key":"3102_CR10","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1111\/cas.15375","volume":"113","author":"YT Zhou","year":"2022","unstructured":"Zhou YT, Yu YQ, Yang H, Yang H, Huo YF, Huang Y, et al. Extracellular ATP promotes angiogenesis and adhesion of TNBC cells to endothelial cells via upregulation of CTGF. Cancer Sci. 2022;113(7):2457\u201371.","journal-title":"Cancer Sci"},{"issue":"1","key":"3102_CR11","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1002\/jcp.21932","volume":"222","author":"K Lindberg","year":"2010","unstructured":"Lindberg K, Str\u00f6m A, Lock JG, Gustafsson J\u00c5, Haldos\u00e9n LA, Helguero LA. Expression of estrogen receptor \u03b2 increases integrin \u03b11 and integrin \u03b21 levels and enhances adhesion of breast cancer cells. J Cell Physiol. 2010;222(1):156\u201367.","journal-title":"J Cell Physiol"},{"issue":"8","key":"3102_CR12","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21082995","volume":"21","author":"R Machado Brand\u00e3o-Costa","year":"2020","unstructured":"Machado Brand\u00e3o-Costa R, Helal-Neto E, Maia Vieira A, Barcellos-de-Souza P, Morgado-Diaz J, Barja-Fidalgo C. Extracellular matrix derived from high metastatic human breast cancer triggers epithelial-mesenchymal transition in epithelial breast cancer cells through \u03b1v\u03b23 integrin. Int J Mol Sci. 2020;21(8):2995.","journal-title":"Int J Mol Sci"},{"key":"3102_CR13","doi-asserted-by":"crossref","DOI":"10.1186\/1475-2867-7-16","volume":"7","author":"S Havaki","year":"2007","unstructured":"Havaki S, Kouloukoussa M, Amawi K, Drosos Y, Arvanitis LD, Goutas N, et al. Altered expression pattern of integrin alphavbeta3 correlates with actin cytoskeleton in primary cultures of human breast cancer. Cancer Cell Int. 2007;7:16.","journal-title":"Cancer Cell Int"},{"issue":"2","key":"3102_CR14","doi-asserted-by":"crossref","first-page":"301","DOI":"10.31557\/apjcb.2025.10.2.301-307","volume":"10","author":"HH Vora","year":"2025","unstructured":"Vora HH. Identification of extra cellular matrix (ECM) genes in triple negative breast cancer. Asian Pac J Cancer Biol. 2025;10(2):301\u20137.","journal-title":"Asian Pac J Cancer Biol"},{"issue":"2","key":"3102_CR15","doi-asserted-by":"crossref","DOI":"10.1186\/bcr1983","volume":"10","author":"A Thompson","year":"2008","unstructured":"Thompson A, Brennan K, Cox A, Gee J, Harcourt D, Harris A, et al. Evaluation of the current knowledge limitations in breast cancer research: a gap analysis. Breast Cancer Res. 2008;10(2):R26.","journal-title":"Breast Cancer Res"},{"key":"3102_CR16","volume":"17","author":"MU Rashid","year":"2019","unstructured":"Rashid MU, Muhammad N, Naeemi H, Khan FA, Hassan M, Faisal S, et al. Spectrum and prevalence of BRCA1\/2 germline mutations in Pakistani breast cancer patients: results from a large comprehensive study. Hereditary Cancer in Clinical Practice. 2019;17:27.","journal-title":"Hereditary Cancer in Clinical Practice"},{"key":"3102_CR17","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1251\/bpo37","volume":"4","author":"W Bao","year":"2002","unstructured":"Bao W, Str\u00f6mblad S. Use of an immobilized monoclonal antibody to examine integrin \u03b15\u03b21 signaling independent of cell spreading. Biol Proced Online. 2002;4:81\u20137.","journal-title":"Biol Proced Online"},{"issue":"1","key":"3102_CR18","volume":"10","author":"GA Arias-Pinilla","year":"2020","unstructured":"Arias-Pinilla GA, Dalgleish AG, Mudan S, Bagwan I, Walker AJ, Modjtahedi H. Development and application of two novel monoclonal antibodies against overexpressed CD26 and integrin \u03b13 in human pancreatic cancer. Sci Rep. 2020;10(1):537.","journal-title":"Sci Rep"},{"issue":"9","key":"3102_CR19","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0204209","volume":"13","author":"MA Chellaiah","year":"2018","unstructured":"Chellaiah MA, Majumdar S, Aljohani H. Peptidomimetic inhibitors of L-plastin reduce the resorptive activity of osteoclast but not the bone forming activity of osteoblasts in vitro. PLoS One. 2018;13(9):e0204209.","journal-title":"PLoS One"},{"key":"3102_CR20","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2013.00222","volume":"3","author":"UK Marelli","year":"2013","unstructured":"Marelli UK, Rechenmacher F, Sobahi TRA, Mas-Moruno C, Kessler H. Tumor targeting via integrin ligands. Front Oncol. 2013;3:222.","journal-title":"Front Oncol"},{"issue":"10","key":"3102_CR21","doi-asserted-by":"crossref","first-page":"8074","DOI":"10.1002\/jcb.26727","volume":"119","author":"EE Hill","year":"2018","unstructured":"Hill EE, Kim JK, Jung Y, Neeley CK, Pienta KJ, Taichman RS, et al. Integrin alpha V beta 3 targeted dendrimer-rapamycin conjugate reduces fibroblast-mediated prostate tumor progression and metastasis. J Cell Biochem. 2018;119(10):8074\u201383.","journal-title":"J Cell Biochem"},{"issue":"1","key":"3102_CR22","volume":"15","author":"FA Khan","year":"2024","unstructured":"Khan FA, Fang N, Zhang W, Ji S. The multifaceted role of Fragile X-Related Protein 1 (FXR1) in cellular processes: an updated review on cancer and clinical applications. Cell Death Dis. 2024;15(1):72.","journal-title":"Cell Death Dis"},{"key":"3102_CR23","doi-asserted-by":"publisher","DOI":"10.36922\/gpd.5068","author":"FA Khan","year":"2025","unstructured":"Khan FA, Ji X-Y, Ji S, Dong J. FXR1 modulates the expression of oncogenes and tumor suppressor genes associated with poor cancer prognosis. GPD. 2025. https:\/\/doi.org\/10.36922\/gpd.5068.","journal-title":"GPD"},{"issue":"3","key":"3102_CR24","doi-asserted-by":"crossref","first-page":"992","DOI":"10.4143\/crt.2018.356","volume":"51","author":"MU Rashid","year":"2019","unstructured":"Rashid MU, Khan FA, Muhammad N, Loya A, Hamann U. Prevalence of PALB2 germline mutations in early-onset and familial breast\/ovarian cancer patients from Pakistan. Cancer Res Treat. 2019;51(3):992\u20131000.","journal-title":"Cancer Res Treat"},{"key":"3102_CR25","doi-asserted-by":"crossref","unstructured":"Edgar R, Domrachev M, Lash AE. Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic acids research. 2002;30(1):207\u201310.","DOI":"10.1093\/nar\/30.1.207"},{"key":"3102_CR26","doi-asserted-by":"crossref","unstructured":"Maubant S, Tesson B, Maire V, Ye M, Rigaill G, Gentien D, et al. Transcriptome analysis of Wnt3a-treated triple-negative breast cancer cells. PloS one. 2015;10(4):e0122333.","DOI":"10.1371\/journal.pone.0122333"},{"key":"3102_CR27","doi-asserted-by":"crossref","unstructured":"Gruosso T, Mieulet V, Cardon M, Bourachot B, Kieffer Y, Devun F, et al. Chronic oxidative stress promotes H2 AX protein degradation and enhances chemosensitivity in breast cancer patients. EMBO Molecular Med. 2016;8(5):527\u201349.","DOI":"10.15252\/emmm.201505891"},{"key":"3102_CR28","doi-asserted-by":"crossref","unstructured":"Clarke C, Madden SF, Doolan P, Aherne ST, Joyce H, O\u2019driscoll L, et al. Correlating transcriptional networks to breast cancer survival: a large-scale coexpression analysis. Carcinogenesis. 2013;34(10):2300\u20138.","DOI":"10.1093\/carcin\/bgt208"},{"key":"3102_CR29","doi-asserted-by":"crossref","unstructured":"Colak D, Nofal A, AlBakheet A, Nirmal M, Jeprel H, Eldali A, et al. Age-specific gene expression signatures for breast tumors and cross-species conserved potential cancer progression markers in young women. PloS one. 2013;8(5):e63204.","DOI":"10.1371\/journal.pone.0063204"},{"key":"3102_CR30","doi-asserted-by":"crossref","unstructured":"Ni IBP, Zakaria Z, Muhammad R, Abdullah N, Ibrahim N, Emran NA, et al. Gene expression patterns distinguish breast carcinomas from normal breast tissues: the Malaysian context. Pathol Res Practice. 2010;206(4):223\u20138.","DOI":"10.1016\/j.prp.2009.11.006"},{"key":"3102_CR31","doi-asserted-by":"crossref","unstructured":"Brouwer-Visser J, Cheng W-Y, Bauer-Mehren A, Maisel D, Lechner K, Andersson E, et al. Regulatory T-cell genes drive altered immune microenvironment in adult solid cancers and allow for immune contextual patient subtyping. Cancer Epidemiol Bio Prevention. 2018;27(1):103\u201312.","DOI":"10.1158\/1055-9965.EPI-17-0461"},{"key":"3102_CR32","doi-asserted-by":"crossref","unstructured":"Diamant I, Clarke DJ, Evangelista JE, Lingam N, Ma\u2019ayan A. Harmonizome 3.0: integrated knowledge about genes and proteins from diverse multi-omics resources. Nucleic Acids Res. 2025;53(D1):D1016\u2013D28.","DOI":"10.1093\/nar\/gkae1080"},{"key":"3102_CR33","doi-asserted-by":"crossref","unstructured":"Tang Z, Kang B, Li C, Chen T, Zhang Z. GEPIA2: an enhanced web server for large-scale expression profiling and interactive analysis. Nucleic Acids Res. 2019;47(W1):W556\u2013W60.","DOI":"10.1093\/nar\/gkz430"},{"key":"3102_CR34","doi-asserted-by":"crossref","unstructured":"Szklarczyk D, Kirsch R, Koutrouli M, Nastou K, Mehryary F, Hachilif R, et al. The STRING database in 2023: protein-protein association networks and functional enrichment analyses for any sequenced genome of interest. Nucleic Acids Res. 2023;51(D1):D638\u2013d46.","DOI":"10.1093\/nar\/gkac1000"},{"key":"3102_CR35","doi-asserted-by":"crossref","unstructured":"Huang HY, Lin YC, Cui S, Huang Y, Tang Y, Xu J, et al. miRTarBase update 2022: an informative resource for experimentally validated miRNA-target interactions. Nucleic Acids Res. 2022;50(D1):D222\u2013D30.","DOI":"10.1093\/nar\/gkab1079"},{"key":"3102_CR36","doi-asserted-by":"crossref","unstructured":"Li R, Qu H, Wang S, Chater JM, Wang X, Cui Y, et al. CancerMIRNome: an interactive analysis and visualization database for miRNome profiles of human cancer. Nucleic Acids Res. 2022;50(D1):D1139\u2013D46.","DOI":"10.1093\/nar\/gkab784"},{"key":"3102_CR37","doi-asserted-by":"crossref","unstructured":"Li JH, Liu S, Zhou H, Qu LH, Yang JH. starBase v2.0: decoding miRNA-ceRNA, miRNA-ncRNA and protein-RNA interaction networks from large-scale CLIP-Seq data. Nucleic Acids Res. 2014;42(Database issue):D92\u20137.","DOI":"10.1093\/nar\/gkt1248"},{"key":"3102_CR38","doi-asserted-by":"crossref","unstructured":"Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003;13(11):2498\u2013504.","DOI":"10.1101\/gr.1239303"},{"key":"3102_CR39","doi-asserted-by":"crossref","unstructured":"Li Z, Zhang Y, Fang J, Xu Z, Zhang H, Mao M, et al. NcPath: a novel platform for visualization and enrichment analysis of human non-coding RNA and KEGG signaling pathways. Bioinformatics (Oxford, England). 2023;39(1).","DOI":"10.1093\/bioinformatics\/btac812"},{"key":"3102_CR40","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.neo.2022.01.001","volume":"25","author":"DS Chandrashekar","year":"2022","unstructured":"Chandrashekar DS, Karthikeyan SK, Korla PK, Patel H, Shovon AR, Athar M, et al. Ualcan: an update to the integrated cancer data analysis platform. Neoplasia. 2022;25:18\u201327.","journal-title":"Neoplasia"},{"key":"3102_CR41","doi-asserted-by":"crossref","unstructured":"Yingtaweesittikul H, Wu J, Mongia A, Peres R, Ko K, Nagarajan N, et al. CREAMMIST: an integrative probabilistic database for cancer drug response prediction. Nucleic Acids Res. 2023;51(D1):D1242\u2013D8.","DOI":"10.1093\/nar\/gkac911"},{"key":"3102_CR42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2021\/5561651","volume":"2021","author":"H Bao","year":"2021","unstructured":"Bao H, Huo Q, Yuan Q, Xu C. Fibronectin 1: a potential biomarker for ovarian cancer. Dis Markers. 2021;2021:1\u201311.","journal-title":"Dis Markers"},{"key":"3102_CR43","doi-asserted-by":"crossref","unstructured":"wu y, Zhang C, Zou L, et al. FN1 Is a Prognostic Biomarker and Correlated With Immune Infiltrates in Thyroid Carcinoma and Breast Invasive Carcinoma. Research Square; 2022.","DOI":"10.21203\/rs.3.rs-1470440\/v1"},{"key":"3102_CR44","doi-asserted-by":"publisher","DOI":"10.56434\/j.arch.esp.urol.20237601.7","author":"X Zhang","year":"2023","unstructured":"Zhang X, Liu H, Zhang J, Wang Z, Yang S, Liu D, et al. Fibronectin-1: a predictive immunotherapy response biomarker for muscle invasive bladder cancer. Arch Esp Urol. 2023. https:\/\/doi.org\/10.56434\/j.arch.esp.urol.20237601.7.","journal-title":"Arch Esp Urol"},{"key":"3102_CR45","volume":"12","author":"H Wang","year":"2022","unstructured":"Wang H, Zhang J, Li H, Yu H, Chen S, Liu S, et al. FN1 is a prognostic biomarker and correlated with immune infiltrates in gastric cancers. Front Oncol. 2022;12:918719.","journal-title":"Front Oncol"},{"key":"3102_CR46","doi-asserted-by":"publisher","DOI":"10.2147\/IJGM.S364708","author":"W-H Zhou","year":"2022","unstructured":"Zhou W-H, Du W-D, Li Y-F, Al-Aroomi MA, Yan C, Wang Y, et al. The overexpression of fibronectin 1 promotes cancer progression and associated with M2 macrophages polarization in head and neck squamous cell carcinoma patients. Int J Gen Med. 2022. https:\/\/doi.org\/10.2147\/IJGM.S364708.","journal-title":"Int J Gen Med"},{"issue":"29","key":"3102_CR47","doi-asserted-by":"crossref","first-page":"45702","DOI":"10.18632\/oncotarget.10157","volume":"7","author":"C Zhang","year":"2016","unstructured":"Zhang C, Wu M, Zhang L, Shang LR, Fang JH, Zhuang SM. Fibrotic microenvironment promotes the metastatic seeding of tumor cells via activating the fibronectin 1\/secreted phosphoprotein 1-integrin signaling. Oncotarget. 2016;7(29):45702\u201314.","journal-title":"Oncotarget"},{"key":"3102_CR48","volume":"13","author":"X-X Zhang","year":"2022","unstructured":"Zhang X-X, Luo J-H, Wu L-Q. FN1 overexpression is correlated with unfavorable prognosis and immune infiltrates in breast cancer. Front Genet. 2022;13:913659.","journal-title":"Front Genet"},{"issue":"3","key":"3102_CR49","doi-asserted-by":"crossref","DOI":"10.21037\/cco-23-36","volume":"12","author":"SN Gregory","year":"2023","unstructured":"Gregory SN, Davis JL. CDH1 and hereditary diffuse gastric cancer: a narrative review. Chin Clin Oncol. 2023;12(3):25.","journal-title":"Chin Clin Oncol"},{"key":"3102_CR50","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2023.41.16_suppl.10524","author":"H Abdel-Salam","year":"2023","unstructured":"Abdel-Salam H, Mansfield PF, Moskowitz JB, Arun B, American Society of Clinical Oncology. CDH1 incidental findings in patients with personal or family history of breast cancer. J Clin Oncol. 2023. https:\/\/doi.org\/10.1200\/JCO.2023.41.16_suppl.10524.","journal-title":"J Clin Oncol"},{"issue":"1","key":"3102_CR51","doi-asserted-by":"crossref","first-page":"73-btii","DOI":"10.1097\/CEJ.0000000000000824","volume":"33","author":"DR Belut","year":"2024","unstructured":"Belut DR, Lima EdO, Zanini MA, Galvani AF, Furtado FB, Ferrasi AC. CDH1 hypermethylation: a potential molecular pathway for invasiveness in glioblastoma. Eur J Cancer Prev. 2024;33(1):73-btii.","journal-title":"Eur J Cancer Prev"},{"key":"3102_CR52","doi-asserted-by":"crossref","unstructured":"Zou G, Huang Y, Zhang S, Ko KP, Kim B, Zhang J, Venkatesan V, Pizzi MP, Fan Y, Jun S, Niu N, Wang H, Song S, Ajani JA, Park JI. CDH1 loss promotes diffuse-type gastric cancer tumorigenesis via epigenetic reprogramming and immune evasion. bioRxiv [Preprint]. 2023;2023.03.23.533976.","DOI":"10.1101\/2023.03.23.533976"},{"issue":"1","key":"3102_CR53","volume":"13","author":"H Ma","year":"2022","unstructured":"Ma H, Qiu Q, Tan D, Chen Q, Liu Y, Chen B, et al. The cancer-associated fibroblasts-related gene COMP is a novel predictor for prognosis and immunotherapy efficacy and is correlated with M2 macrophage infiltration in colon cancer. Biomolecules. 2022;13(1):62.","journal-title":"Biomolecules"},{"key":"3102_CR54","doi-asserted-by":"crossref","first-page":"3992","DOI":"10.1007\/s00464-019-07185-z","volume":"34","author":"V Nfonsam","year":"2020","unstructured":"Nfonsam V, Jecius H, Janda J, Omesiete P, Elquza E, Scott A, et al. Cartilage oligomeric matrix protein (COMP) promotes cell proliferation in early-onset colon cancer tumorigenesis. Surg Endosc. 2020;34:3992\u20138.","journal-title":"Surg Endosc"},{"issue":"12","key":"3102_CR55","volume":"12","author":"J-T Ding","year":"2022","unstructured":"Ding J-T, Zhou H-N, Huang Y-F, Peng J, Huang H-Y, Yi H, et al. TGF-\u03b2 pathways stratify colorectal cancer into two subtypes with distinct cartilage oligomeric matrix protein (COMP) expression-related characteristics. Biomolecules. 2022;12(12):1877.","journal-title":"Biomolecules"},{"key":"3102_CR56","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2019.01141","volume":"9","author":"KS Papadakos","year":"2019","unstructured":"Papadakos KS, Darlix A, Jacot W, Blom AM. High levels of cartilage oligomeric matrix protein in the serum of breast cancer patients can serve as an independent prognostic marker. Front Oncol. 2019;9:1141.","journal-title":"Front Oncol"},{"key":"3102_CR57","volume":"13","author":"Y Guo","year":"2023","unstructured":"Guo Y, Cen K, Yang S, Mai Y, Hong K. Development and validation of an inflammatory response-related signature in triple negative breast cancer for predicting prognosis and immunotherapy. Front Oncol. 2023;13:1175000.","journal-title":"Front Oncol"},{"issue":"8","key":"3102_CR58","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15082250","volume":"15","author":"E Matsubara","year":"2023","unstructured":"Matsubara E, Yano H, Pan C, Komohara Y, Fujiwara Y, Zhao S, et al. The significance of SPP1 in lung cancers and its impact as a marker for protumor tumor-associated macrophages. Cancers (Basel). 2023;15(8):2250.","journal-title":"Cancers (Basel)"},{"issue":"3","key":"3102_CR59","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1080\/07391102.2023.2199871","volume":"42","author":"Y Annadurai","year":"2024","unstructured":"Annadurai Y, Easwaran M, Sundar S, Thangamani L, Meyyazhagan A, Malaisamy A, et al. SPP1, a potential therapeutic target and biomarker for lung cancer: functional insights through computational studies. J Biomol Struct Dyn. 2024;42(3):1336\u201351.","journal-title":"J Biomol Struct Dyn"},{"key":"3102_CR60","doi-asserted-by":"crossref","unstructured":"Zou Y, Tan X, Yuan G, Tang Y, Wang Y, Yang C, et al. SPP1 is expected to be a biomarker for predicting prognosis and immunotherapy efficacy in penile cancer patients. 2022.","DOI":"10.21203\/rs.3.rs-1934794\/v1"},{"issue":"1","key":"3102_CR61","volume":"22","author":"W Gao","year":"2022","unstructured":"Gao W, Liu D, Sun H, Shao Z, Shi P, Li T, et al. SPP1 is a prognostic related biomarker and correlated with tumor-infiltrating immune cells in ovarian cancer. BMC Cancer. 2022;22(1):1367.","journal-title":"BMC Cancer"},{"issue":"6","key":"3102_CR62","first-page":"192","volume":"15","author":"L Rao","year":"2022","unstructured":"Rao L, Cui Z, Xie N, Qi Y, Yang Z, Lan Y. Downregulation of Sp1 suppresses cell proliferation and migration in breast cancer. Int J Clin Exp Med. 2022;15(6):192\u20138.","journal-title":"Int J Clin Exp Med"},{"key":"3102_CR63","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.17219\/acem\/161161","volume":"32","author":"G Wei","year":"2023","unstructured":"Wei G, Tan M, Wang C, Liang L. Decreased miR-127 promotes the occurrence of breast cancer via increasing the expression of SPP1. Adv Clin Exp Med. 2023;32:1113\u201323.","journal-title":"Adv Clin Exp Med"},{"issue":"1","key":"3102_CR64","first-page":"1","volume":"25","author":"M Liang","year":"2023","unstructured":"Liang M, Liu C, Lei T, Guo S, Min J. Effect of integrin \u03b17 on cell proliferation, invasion, apoptosis and the PI3K\/AKT pathway, and its association with clinicopathological features in endometrial cancer. Oncol Lett. 2023;25(1):1\u20139.","journal-title":"Oncol Lett"},{"issue":"17","key":"3102_CR65","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.2217\/bmm-2021-0496","volume":"15","author":"X Zhang","year":"2021","unstructured":"Zhang X, Ke S, Lu Y, An H. ITGA7 relates to disease risk, pathological feature, treatment response and survival in Ph\u2013acute lymphoblastic leukemia. Biomark Med. 2021;15(17):1589\u201397.","journal-title":"Biomark Med"},{"issue":"4","key":"3102_CR66","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1111\/jog.15163","volume":"48","author":"N Yuan","year":"2022","unstructured":"Yuan N, Wang L, Xi Q, Zou N, Zhang X, Lu X, et al. ITGA7, CD133, ALDH1 are inter-correlated, and linked with poor differentiation, lymph node metastasis as well as worse survival in surgical cervical cancer. J Obstet Gynaecol Res. 2022;48(4):1011\u20138.","journal-title":"J Obstet Gynaecol Res"},{"issue":"7","key":"3102_CR67","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1038\/s41416-021-01484-w","volume":"125","author":"N Gwili","year":"2021","unstructured":"Gwili N, Jones SJ, Amri WA, Carr IM, Harris S, Hogan BV, et al. Transcriptome profiles of stem-like cells from primary breast cancers allow identification of ITGA7 as a predictive marker of chemotherapy response. Br J Cancer. 2021;125(7):983\u201393.","journal-title":"Br J Cancer"},{"issue":"8","key":"3102_CR68","volume":"33","author":"X Bai","year":"2019","unstructured":"Bai X, Gao C, Zhang L, Yang S. Integrin \u03b17 high expression correlates with deteriorative tumor features and worse overall survival, and its knockdown inhibits cell proliferation and invasion but increases apoptosis in breast cancer. J Clin Lab Anal. 2019;33(8):e22979.","journal-title":"J Clin Lab Anal"},{"key":"3102_CR69","doi-asserted-by":"publisher","DOI":"10.2147\/CMAR.S160379","author":"A Bhandari","year":"2018","unstructured":"Bhandari A, Xia E, Zhou Y, Guan Y, Xiang J, Kong L, et al. Itga7 functions as a tumor suppressor and regulates migration and invasion in breast cancer. Cancer Manag Res. 2018. https:\/\/doi.org\/10.2147\/CMAR.S160379.","journal-title":"Cancer Manag Res"},{"issue":"1","key":"3102_CR70","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1049\/iet-syb:20060058","volume":"2","author":"KL Yee","year":"2008","unstructured":"Yee KL, Weaver V, Hammer DA. Integrin-mediated signalling through the MAP-kinase pathway. IET Syst Biol. 2008;2(1):8\u201315.","journal-title":"IET Syst Biol"},{"issue":"3","key":"3102_CR71","doi-asserted-by":"crossref","first-page":"245","DOI":"10.4049\/jimmunol.2200016","volume":"210","author":"Y Liu","year":"2023","unstructured":"Liu Y, Wang W, Sun J, Li Y, Wu S, Li Q, et al. CgDM9CP-5-integrin-MAPK pathway regulates the production of CgIL-17s and Cgdefensins in the Pacific oyster, Crassostrea gigas. J Immunol. 2023;210(3):245\u201358.","journal-title":"J Immunol"},{"key":"3102_CR72","unstructured":"Teglov\u00e1 L. Crosstalk of integrin and mTOR signaling. 2010."},{"issue":"1","key":"3102_CR73","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-41095-3","volume":"9","author":"IP Geoghegan","year":"2019","unstructured":"Geoghegan IP, Hoey DA, McNamara LM. Estrogen deficiency impairs integrin \u03b1(v)\u03b2(3)-mediated mechanosensation by osteocytes and alters osteoclastogenic paracrine signalling. Sci Rep. 2019;9(1):4654.","journal-title":"Sci Rep"},{"issue":"7351","key":"3102_CR74","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/nature10152","volume":"474","author":"M Shi","year":"2011","unstructured":"Shi M, Zhu J, Wang R, Chen X, Mi L, Walz T, et al. Latent TGF-\u03b2 structure and activation. Nature. 2011;474(7351):343\u20139.","journal-title":"Nature"},{"issue":"11","key":"3102_CR75","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a005017","volume":"3","author":"JS Munger","year":"2011","unstructured":"Munger JS, Sheppard D. Cross talk among TGF-\u03b2 signaling pathways, integrins, and the extracellular matrix. Cold Spring Harb Perspect Biol. 2011;3(11):a005017.","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"3","key":"3102_CR76","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1007\/s10549-023-07032-9","volume":"201","author":"C Chen","year":"2023","unstructured":"Chen C, Ye L, Yi J, Liu T, Li Z. FN1 mediated activation of aspartate metabolism promotes the progression of triple-negative and luminal a breast cancer. Breast Cancer Res Treat. 2023;201(3):515\u201333.","journal-title":"Breast Cancer Res Treat"},{"key":"3102_CR77","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.jprot.2016.07.033","volume":"148","author":"S Suman","year":"2016","unstructured":"Suman S, Basak T, Gupta P, Mishra S, Kumar V, Sengupta S, et al. Quantitative proteomics revealed novel proteins associated with molecular subtypes of breast cancer. J Proteomics. 2016;148:183\u201393.","journal-title":"J Proteomics"},{"key":"3102_CR78","volume":"13","author":"D Xie","year":"2022","unstructured":"Xie D, Chen Y, Wan X, Li J, Pei Q, Luo Y, et al. The potential role of CDH1 as an oncogene combined with related miRNAs and their diagnostic value in breast cancer. Front Endocrinol. 2022;13:916469.","journal-title":"Front Endocrinol"},{"issue":"Supplement_6","key":"3102_CR79","first-page":"znad241","volume":"110","author":"S Jones","year":"2023","unstructured":"Jones S. WTP8. 13 Expression of Integrin Subunit Alpha 7 (ITGA7) predicts survival from breast cancer following adjuvant chemotherapy. Br J Surg. 2023;110(Supplement_6):znad241.","journal-title":"Br J Surg"},{"issue":"1","key":"3102_CR80","volume":"22","author":"X Yi","year":"2022","unstructured":"Yi X, Luo L, Zhu Y, Deng H, Liao H, Shen Y, et al. SPP1 facilitates cell migration and invasion by targeting COL11A1 in lung adenocarcinoma. Cancer Cell Int. 2022;22(1):324.","journal-title":"Cancer Cell Int"},{"issue":"1","key":"3102_CR81","volume":"15","author":"W Xie","year":"2022","unstructured":"Xie W, Cheng J, Hong Z, Cai W, Zhuo H, Hou J, et al. Multi-transcriptomic analysis reveals the heterogeneity and tumor-promoting role of SPP1\/CD44-mediated intratumoral crosstalk in gastric cancer. Cancers (Basel). 2022;15(1):164.","journal-title":"Cancers (Basel)"},{"issue":"10","key":"3102_CR82","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.4161\/15592294.2014.970077","volume":"9","author":"LB Hesson","year":"2014","unstructured":"Hesson LB, Sloane MA, Wong JW, Nunez AC, Srivastava S, Ng B, et al. Altered promoter nucleosome positioning is an early event in gene silencing. Epigenetics. 2014;9(10):1422\u201330.","journal-title":"Epigenetics"},{"issue":"7","key":"3102_CR83","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1038\/s41379-019-0209-9","volume":"32","author":"M Alsaleem","year":"2019","unstructured":"Alsaleem M, Toss MS, Joseph C, Aleskandarany M, Kurozumi S, Alshankyty I, et al. The molecular mechanisms underlying reduced E-cadherin expression in invasive ductal carcinoma of the breast: high throughput analysis of large cohorts. Mod Pathol. 2019;32(7):967\u201376.","journal-title":"Mod Pathol"},{"issue":"3","key":"3102_CR84","doi-asserted-by":"crossref","first-page":"301","DOI":"10.2217\/epi.13.26","volume":"5","author":"X Ma","year":"2013","unstructured":"Ma X, Wang Y-W, Zhang MQ, Gazdar AF. DNA methylation data analysis and its application to cancer research. Epigenomics. 2013;5(3):301\u201316.","journal-title":"Epigenomics"},{"issue":"1","key":"3102_CR85","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1002\/jcp.28980","volume":"235","author":"J Tang","year":"2020","unstructured":"Tang J, Yang Q, Cui Q, Zhang D, Kong D, Liao X, et al. Weighted gene correlation network analysis identifies RSAD2, HERC5, and CCL8 as prognostic candidates for breast cancer. J Cell Physiol. 2020;235(1):394\u2013407.","journal-title":"J Cell Physiol"},{"issue":"1","key":"3102_CR86","volume":"5","author":"MA Care","year":"2019","unstructured":"Care MA, Westhead DR, Tooze RM. Parsimonious gene correlation network analysis (PGCNA): a tool to define modular gene co-expression for refined molecular stratification in cancer. NPJ Syst Biol Appl. 2019;5(1):13.","journal-title":"NPJ Syst Biol Appl"},{"key":"3102_CR87","doi-asserted-by":"crossref","unstructured":"Quintieri L, Fantin M, Vizier C. Identification of molecular determinants of tumor sensitivity and resistance to anticancer drugs. Microarray Technology and Cancer Gene Profiling. 2007:95\u2013104.","DOI":"10.1007\/978-0-387-39978-2_10"},{"issue":"3","key":"3102_CR88","volume":"22","author":"W Zhang","year":"2022","unstructured":"Zhang W, Ke Y, Liu X, Jin M, Huang G. Drug resistance in NSCLC is associated with tumor micro-environment. Reprod Biol. 2022;22(3):100680.","journal-title":"Reprod Biol"},{"key":"3102_CR89","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12885-018-4446-y","volume":"18","author":"A Naik","year":"2018","unstructured":"Naik A, Al-Yahyaee A, Abdullah N, Sam J-E, Al-Zeheimi N, Yaish MW, et al. Neuropilin-1 promotes the oncogenic Tenascin-C\/integrin \u03b23 pathway and modulates chemoresistance in breast cancer cells. BMC Cancer. 2018;18:1\u201314.","journal-title":"BMC Cancer"},{"issue":"3","key":"3102_CR90","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1038\/sj.bjc.6605511","volume":"102","author":"E Ruiz-Garcia","year":"2010","unstructured":"Ruiz-Garcia E, Scott V, Machavoine C, Bidart JM, Lacroix L, Delaloge S, et al. Gene expression profiling identifies Fibronectin 1 and CXCL9 as candidate biomarkers for breast cancer screening. Br J Cancer. 2010;102(3):462\u20138.","journal-title":"Br J Cancer"},{"issue":"10","key":"3102_CR91","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1038\/s41576-020-0258-4","volume":"21","author":"C Buccitelli","year":"2020","unstructured":"Buccitelli C, Selbach M. mRNAs, proteins and the emerging principles of gene expression control. Nat Rev Genet. 2020;21(10):630\u201344.","journal-title":"Nat Rev Genet"},{"issue":"4","key":"3102_CR92","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1074\/mcp.M200008-MCP200","volume":"1","author":"G Chen","year":"2002","unstructured":"Chen G, Gharib TG, Huang C-C, Taylor JM, Misek DE, Kardia SL, et al. Discordant protein and mRNA expression in lung adenocarcinomas. Mol Cell Proteomics. 2002;1(4):304\u201313.","journal-title":"Mol Cell Proteomics"}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-025-03102-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12032-025-03102-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-025-03102-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T13:07:07Z","timestamp":1776344827000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12032-025-03102-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,25]]},"references-count":92,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,4]]}},"alternative-id":["3102"],"URL":"https:\/\/doi.org\/10.1007\/s12032-025-03102-8","relation":{},"ISSN":["1559-131X"],"issn-type":[{"value":"1559-131X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,25]]},"assertion":[{"value":"29 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"This research was approved by the ethics committee of Hormozgan University of Medical Science (Ethical code: #IR.HUMS.REC.1400.394).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics statement"}}],"article-number":"159"}}